Provided by Tiger Trade Technology Pte. Ltd.

Talis Biomedical Corporation

2.84
0.0000
Volume:- -
Turnover:- -
Market Cap:5.18M
PE:-0.10
High:2.84
Open:2.84
Low:2.84
Close:2.84
52wk High:2.84
52wk Low:1.04
Shares:1.82M
Float Shares:914.17K
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-28.0189
EPS(LYR):-34.1165
ROE:-70.48%
ROA:-29.59%
PB:0.11
PE(LYR):-0.08

Loading ...

Mar 22, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2023

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 12, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 02, 2022

Major Issues Report

8-K - Current report
Aug 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 13, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 10, 2022

Major Issues Report

8-K - Current report
Jun 02, 2022

Major Issues Report

8-K - Current report
May 20, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 22, 2022

Major Issues Report

8-K - Current report